Puri Raj K. 4
4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Mar 11, 2026
Research Summary
AI-generated summary of this filing
IOVANCE (IOVA) Chief Regulatory Officer Puri Raj K. Receives Award
What Happened Puri Raj K., IOVANCE Biotherapeutics' Chief Regulatory Officer, received an award of 117,500 restricted stock units (RSUs) on March 9, 2026. The award is reported as a derivative grant (transaction code A) at $0.00 per unit — i.e., a compensatory RSU grant, not a market purchase or sale.
Key Details
- Transaction date: 2026-03-09; Form 4 filed: 2026-03-11 (reported within the typical two-business-day window).
- Grant: 117,500 RSUs; reported price: $0.00; reported value at grant: $0 (compensatory award).
- Post-transaction ownership: Not specified in the filing.
- Footnotes: Each RSU represents a contingent right to one share. Vesting: one-third on the one-year anniversary of the grant, then the remaining two-thirds vest in eight equal quarterly installments over the following two years (vesting commences the first quarter after the first anniversary).
- Transaction type: Award/Grant (derivative); no sale or purchase of shares occurred.
Context RSUs are compensation that convert into shares if and when vesting conditions are met; they do not indicate an immediate cash investment or sale by the insider. This is a routine executive equity grant used for retention and compensation; it should be interpreted as a future potential issuance of shares upon vesting, not an immediate change in market holdings.
Insider Transaction Report
- Award
Restricted Stock Units
[F1][F2]2026-03-09+117,500→ 117,500 total→ Common stock (117,500 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.